These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19923179)

  • 1. HIV-1 Vpr oligomerization but not that of Gag directs the interaction between Vpr and Gag.
    Fritz JV; Dujardin D; Godet J; Didier P; De Mey J; Darlix JL; Mély Y; de Rocquigny H
    J Virol; 2010 Feb; 84(3):1585-96. PubMed ID: 19923179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of Vpr into human immunodeficiency virus type 1 requires a direct interaction with the p6 domain of the p55 gag precursor.
    Bachand F; Yao XJ; Hrimech M; Rougeau N; Cohen EA
    J Biol Chem; 1999 Mar; 274(13):9083-91. PubMed ID: 10085158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.
    Accola MA; Strack B; Göttlinger HG
    J Virol; 2000 Jun; 74(12):5395-402. PubMed ID: 10823843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses.
    Selig L; Pages JC; Tanchou V; Prévéral S; Berlioz-Torrent C; Liu LX; Erdtmann L; Darlix J; Benarous R; Benichou S
    J Virol; 1999 Jan; 73(1):592-600. PubMed ID: 9847364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The zinc fingers of HIV nucleocapsid protein NCp7 direct interactions with the viral regulatory protein Vpr.
    de Rocquigny H; Petitjean P; Tanchou V; Decimo D; Drouot L; Delaunay T; Darlix JL; Roques BP
    J Biol Chem; 1997 Dec; 272(49):30753-9. PubMed ID: 9388214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1 assembly and lipid rafts: Pr55(gag) associates with membrane domains that are largely resistant to Brij98 but sensitive to Triton X-100.
    Holm K; Weclewicz K; Hewson R; Suomalainen M
    J Virol; 2003 Apr; 77(8):4805-17. PubMed ID: 12663787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical analyses of the interactions between human immunodeficiency virus type 1 Vpr and p6(Gag).
    Jenkins Y; Pornillos O; Rich RL; Myszka DG; Sundquist WI; Malim MH
    J Virol; 2001 Nov; 75(21):10537-42. PubMed ID: 11581428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles.
    Lu YL; Bennett RP; Wills JW; Gorelick R; Ratner L
    J Virol; 1995 Nov; 69(11):6873-9. PubMed ID: 7474102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for direct association of Vpr and matrix protein p17 within the HIV-1 virion.
    Sato A; Yoshimoto J; Isaka Y; Miki S; Suyama A; Adachi A; Hayami M; Fujiwara T; Yoshie O
    Virology; 1996 Jun; 220(1):208-12. PubMed ID: 8659115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A conserved dileucine-containing motif in p6(gag) governs the particle association of Vpx and Vpr of simian immunodeficiency viruses SIV(mac) and SIV(agm).
    Accola MA; Bukovsky AA; Jones MS; Göttlinger HG
    J Virol; 1999 Dec; 73(12):9992-9. PubMed ID: 10559313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles.
    Lavallée C; Yao XJ; Ladha A; Göttlinger H; Haseltine WA; Cohen EA
    J Virol; 1994 Mar; 68(3):1926-34. PubMed ID: 8107252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Vpr Abrogates the Effect of TSG101 Overexpression to Support Virus Release.
    Chutiwitoonchai N; Siarot L; Takeda E; Shioda T; Ueda M; Aida Y
    PLoS One; 2016; 11(9):e0163100. PubMed ID: 27648839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C-terminal p6 domain of the HIV-1 Pr55
    Dubois N; Khoo KK; Ghossein S; Seissler T; Wolff P; McKinstry WJ; Mak J; Paillart JC; Marquet R; Bernacchi S
    RNA Biol; 2018; 15(7):923-936. PubMed ID: 29954247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding.
    Ono A; Demirov D; Freed EO
    J Virol; 2000 Jun; 74(11):5142-50. PubMed ID: 10799589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel fluorescence resonance energy transfer assay demonstrates that the human immunodeficiency virus type 1 Pr55Gag I domain mediates Gag-Gag interactions.
    Derdowski A; Ding L; Spearman P
    J Virol; 2004 Feb; 78(3):1230-42. PubMed ID: 14722278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles.
    Kondo E; Mammano F; Cohen EA; Göttlinger HG
    J Virol; 1995 May; 69(5):2759-64. PubMed ID: 7707498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency virus type 1 Vpr.
    Kondo E; Göttlinger HG
    J Virol; 1996 Jan; 70(1):159-64. PubMed ID: 8523520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein.
    Liu H; Wu X; Xiao H; Conway JA; Kappes JC
    J Virol; 1997 Oct; 71(10):7704-10. PubMed ID: 9311854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis.
    Paxton W; Connor RI; Landau NR
    J Virol; 1993 Dec; 67(12):7229-37. PubMed ID: 8230445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of the C-terminus of viral protein R with nucleic acids are modulated by its N-terminus.
    de Rocquigny H; Caneparo A; Delaunay T; Bischerour J; Mouscadet JF; Roques BP
    Eur J Biochem; 2000 Jun; 267(12):3654-60. PubMed ID: 10848983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.